▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3782 by analyst upside · 2026-09-27
VEEV
Veeva Systems Inc.
Healthcare · Market Cap $45B · P/E 46.1x
ANALYST PRICE TARGET
+5.9%
implied upside to consensus target
Current Price $280.68
Consensus Target $297.3
Bull Target $350.0
Bear Target $180.0
Analysts Covering 27
ANALYST CONSENSUS - BUY
Strong Buy
7
Buy
11
Hold
7
Sell
2
52-Week Low $148.05
52-Week High $310.5
YTD Return +27.9%
FUNDAMENTALS
Market Cap $45B
P/E Ratio (TTM) 46.1x
Forward P/E 27.4x
EPS (TTM) $6.09
PEG Ratio 1.25
Dividend Yield N/A
Revenue (TTM) $3.5B
Profit Margin 29.3%
52-WEEK RANGE
52-Week Low $148.05
52-Week High $310.5
Current Price $280.68
Bear Target $180.0
Bull Target $350.0
● Now $280.68 ● Target $297.3
TRADING DATA
Avg Volume 1.8M
YTD Return +27.9%
Analyst Count 27
Consensus Buy
Upside to Target +5.9%
Last Updated 2026-09-27

ANALYST SUMMARY

Veeva Systems Inc. (VEEV) is currently trading at $280.68 with a Wall Street consensus price target of $297.3, implying potential upside of 5.9% over the next 12 months. 27 analysts currently cover VEEV, with a consensus rating of Buy - 67% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $350.0, while the most cautious has a target of $180.0.

VEEV operates in the Healthcare sector with a market capitalisation of $45B. The stock is up 27.9% year-to-date and is currently trading near the upper end of its 52-week range of $148.05 – $310.5.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for VEEV, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Citigroup - Reiterated
Neutral → Neutral 2026-08-28 Building track record
Mizuho - Reiterated
Outperform → Outperform 2026-08-27 Building track record
BMO Capital - Reiterated
Market Perform → Market Perform 2026-08-27 Building track record
Baird - Reiterated
Outperform → Outperform 2026-08-27 Building track record
Canaccord Genuity - Reiterated
Hold → Hold 2026-08-27 Building track record
TD Cowen - Reiterated
Buy → Buy 2026-08-27 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-08-27 Building track record
UBS - Reiterated
Neutral → Neutral 2026-08-27 33% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
57
out of 100
Coverage depth
25/30
Consensus clarity
18/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →